Hinge Health's chief financial officer, Budge James, reported the trades in a Form 4 filing, an SEC report of insider stock trades. The sales took place on October 12, 2026. The report was filed on October 13, one day later.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-12 |
| Date of Latest Transaction | 2026-10-12 |
| Buy/Sell | sell |
| Transaction Count | 4 |
| Shares Transacted | 47,720 |
| Price | $103.13 |
| Total Transaction Value | $4,921,577.71 |
| Insider | |
| Ticker Symbol | HNGE |
| Company | Hinge Health, Inc. |
| Insider Name | Budge James |
| Insider Title | Chief Financial Officer |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 296,728 |
| Position Size Change | 13.85% |
| Filing | |
| Filing Date | 2026-10-13 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were share sales, reported with transaction code S. The filing information lists four transactions in HNGE shares.
What was the average price of the transaction?
The average sale price was $103.13 per share, rounded to the nearest cent. That average covers the four transactions. Separate prices for each sale are not available in the transaction details.
How did this transaction affect the insider's holdings?
After selling 47,720 shares, Budge James reported owning 296,728 shares. The sales covered 13.85% of the shares owned before the trades.
What's the total transaction value?
The total value of the four sales was $4,921,577.71, rounded to the nearest cent.
Are there any special circumstances around this transaction?
The available filing details include a Rule 10b5-1 trading-plan reference. Such plans set trading instructions in advance. The reference may apply to the filing as a whole. Footnote text is not available to confirm which of the four sales the plan covers. The plan's terms and when it was set up are unknown.
For research purposes only; not investment advice.